User:Juergen Mairhofer

From OpenWetWare
Revision as of 10:45, 24 March 2010 by Juergen Mairhofer (talk | contribs)
(diff) ← Older revision | Latest revision (diff) | Newer revision → (diff)
Jump to: navigation, search

Contact Info

Juergen Mairhofer (an artistic interpretation)
  • Juergen Mairhofer
  • University of Natural Resources and Applied Life Sciences, Vienna
  • Vienna Institute of BioTechnology (VIBT)
  • Muthgasse 11
  • A-1190 Vienna, Austria
  • Email me through OpenWetWare

tba

Education

tba

Research interests

  1. Sytnthetic Biology
  2. Systems Biology
  3. E. coli host engineering
  4. Applied Microbiology / Bioprocessing

Publications

  1. Mairhofer J, Cserjan-Puschmann M, Striedner G, Nöbauer K, Razzazi-Fazeli E, and Grabherr R. Marker-free plasmids for gene therapeutic applications--lack of antibiotic resistance gene substantially improves the manufacturing process. J Biotechnol. 2010 Apr 1;146(3):130-7. DOI:10.1016/j.jbiotec.2010.01.025 | PubMed ID:20138928 | HubMed [Paper1]
    recent paper on the production of marker-free plasmid DNA using E. coli strain JM108
  2. Mairhofer J and Grabherr R. Rational vector design for efficient non-viral gene delivery: challenges facing the use of plasmid DNA. Mol Biotechnol. 2008 Jun;39(2):97-104. DOI:10.1007/s12033-008-9046-7 | PubMed ID:18327557 | HubMed [Paper2]
  3. Mairhofer J, Pfaffenzeller I, Merz D, and Grabherr R. A novel antibiotic free plasmid selection system: advances in safe and efficient DNA therapy. Biotechnol J. 2008 Jan;3(1):83-9. DOI:10.1002/biot.200700141 | PubMed ID:17806101 | HubMed [Paper3]
  4. Pfaffenzeller I, Mairhofer J, Striedner G, Bayer K, and Grabherr R. Using ColE1-derived RNA I for suppression of a bacterially encoded gene: implication for a novel plasmid addiction system. Biotechnol J. 2006 Jun;1(6):675-81. DOI:10.1002/biot.200600017 | PubMed ID:16892316 | HubMed [Paper4]
All Medline abstracts: PubMed | HubMed

Useful links